Observational studyMedicine2024

Comparative analysis of doublet chemotherapy regimens plus bevacizumab in patients with recurrent ovarian cancer.

Ni Jat Khanmammadov et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.